Skip to main content
Top
Published in: Quality of Life Research 2/2010

Open Access 01-03-2010

Quality of life, characteristics and survival of patients with HIV and lymphoma

Authors: Catherine Diamond, Thomas H. Taylor, Hoda Anton-Culver

Published in: Quality of Life Research | Issue 2/2010

Login to get access

Abstract

Purpose

We sought to compare the quality of life (QOL), characteristics, and survival of patients with non-Hodgkin lymphoma (NHL) with and without human immunodeficiency virus (HIV) infection.

Methods

Using the population-based cancer registry for Orange and San Diego Counties, We recruited 50 patients with HIV and systemic NHL (cases) and 50 age, sex and race-matched NHL patients without HIV (controls) diagnosed with NHL during 2002–2006. Patients completed a medical history survey and QOL instrument, the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) for cases and Functional Assessment of Cancer Therapy-General (FACT G) for controls.

Results

HIV-infected patients had worse overall QOL and survival than uninfected patients. QOL differences were more marked in the areas of functional, physical and social well-being than in the area of emotional well-being. HIV-infected patients had lower income and were less likely to have private insurance and more likely to have diffuse large B cell histology than uninfected patients.

Conclusion

HIV-infected NHL patients had worse QOL and survival than uninfected patients, due to a combination of co-morbidity, aggressive histology and lack of social support. However, their emotional well-being was comparable to that of uninfected NHL patients and better than historical norms for the HIV-infected.
Literature
1.
go back to reference Coté, T. R., Biggar, R. J., Rosenberg, P. S., Devesa, S. S., Percy, C., Yellin, F. J., et al. (1997). Non-Hodgkin’s lymphoma among people with AIDS: Incidence, presentation and public health burden. AIDS/cancer study group. International Journal of Cancer, 73, 645–650.CrossRef Coté, T. R., Biggar, R. J., Rosenberg, P. S., Devesa, S. S., Percy, C., Yellin, F. J., et al. (1997). Non-Hodgkin’s lymphoma among people with AIDS: Incidence, presentation and public health burden. AIDS/cancer study group. International Journal of Cancer, 73, 645–650.CrossRef
2.
go back to reference Bellizzi, K. M., Rowland, J. H., Arora, N. K., Hamilton, A. S., Miller, M. F., & Aziz, N. M. (2009). Physical activity and quality of life in adult survivors of non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 27, 960–966.CrossRefPubMed Bellizzi, K. M., Rowland, J. H., Arora, N. K., Hamilton, A. S., Miller, M. F., & Aziz, N. M. (2009). Physical activity and quality of life in adult survivors of non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 27, 960–966.CrossRefPubMed
3.
go back to reference Remick, S. C., Sedransk, N., Haase, R. F., Blanchard, C. G., Ramnes, C. R., Nazeer, T., et al. (2001). Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin’s lymphoma: Evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up. American Journal of Hematology, 66, 178–188.CrossRefPubMed Remick, S. C., Sedransk, N., Haase, R. F., Blanchard, C. G., Ramnes, C. R., Nazeer, T., et al. (2001). Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin’s lymphoma: Evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up. American Journal of Hematology, 66, 178–188.CrossRefPubMed
4.
go back to reference Martí-Carvajal, A. J., Cardona, A. F., Lawrence, A. (2009). Interventions for previously untreated patients with AIDS-associated Non-Hodgkin′s Lymphoma. Cochrane Database of Systematic Reviews, 3, CD005419. Martí-Carvajal, A. J., Cardona, A. F., Lawrence, A. (2009). Interventions for previously untreated patients with AIDS-associated Non-Hodgkin′s Lymphoma. Cochrane Database of Systematic Reviews, 3, CD005419.
5.
go back to reference Diamond, C., Taylor, T. H., Aboumrad, T., & Anton-Culver, H. (2006). Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Incidence, presentation, treatment, and survival. Cancer, 106, 128–135.CrossRefPubMed Diamond, C., Taylor, T. H., Aboumrad, T., & Anton-Culver, H. (2006). Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Incidence, presentation, treatment, and survival. Cancer, 106, 128–135.CrossRefPubMed
6.
go back to reference Boué, F., Gabarre, J., Gisselbrecht, C., Reynes, J., Cheret, A., Bonnet, F., et al. (2006). Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 24, 4123–4128.CrossRefPubMed Boué, F., Gabarre, J., Gisselbrecht, C., Reynes, J., Cheret, A., Bonnet, F., et al. (2006). Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 24, 4123–4128.CrossRefPubMed
7.
go back to reference Centers for Disease Control and Prevention (2009). HIV/AIDS surveillance report, 2007. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, 19: 12. Centers for Disease Control and Prevention (2009). HIV/AIDS surveillance report, 2007. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, 19: 12.
8.
go back to reference Goldman, D. P., Leibowitz, A. A., Joyce, G. F., Fleishman, J. A., Bozzette, S. A., Duan, N., et al. (2003). Insurance status of HIV-infected adults in the post-HAART era: evidence from the United States. Applied Health Economics and Health Policy, 2, 85–90.PubMed Goldman, D. P., Leibowitz, A. A., Joyce, G. F., Fleishman, J. A., Bozzette, S. A., Duan, N., et al. (2003). Insurance status of HIV-infected adults in the post-HAART era: evidence from the United States. Applied Health Economics and Health Policy, 2, 85–90.PubMed
9.
go back to reference Diamond, C., Taylor, T. H., Im, T., Wallace, M., Saven, A., & Anton-Culver, H. (2007). How valid is using cancer registries’ data to identify acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma? Cancer Causes and Control, 18, 135–142.CrossRefPubMed Diamond, C., Taylor, T. H., Im, T., Wallace, M., Saven, A., & Anton-Culver, H. (2007). How valid is using cancer registries’ data to identify acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma? Cancer Causes and Control, 18, 135–142.CrossRefPubMed
10.
go back to reference Cella, D. F., McCain, N. L., Peterman, A. H., Mo, F., & Wolen, D. (1996). Development and validation of the Functional assessment of human immunodeficiency virus infection (FAHI) quality of life instrument. Quality of Life Research, 5, 450–463.CrossRefPubMed Cella, D. F., McCain, N. L., Peterman, A. H., Mo, F., & Wolen, D. (1996). Development and validation of the Functional assessment of human immunodeficiency virus infection (FAHI) quality of life instrument. Quality of Life Research, 5, 450–463.CrossRefPubMed
11.
go back to reference Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11, 570–579.PubMed Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11, 570–579.PubMed
12.
go back to reference Cella, D., Hernandez, L., Bonomi, A. E., Corona, M., Vaquero, M., Shiomoto, G., et al. (1998). Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. Medical Care, 36, 1407–1418.CrossRefPubMed Cella, D., Hernandez, L., Bonomi, A. E., Corona, M., Vaquero, M., Shiomoto, G., et al. (1998). Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. Medical Care, 36, 1407–1418.CrossRefPubMed
13.
go back to reference Peterman, A. H., Cella, D., Mo, F., & McCain, N. (1997). Psychometric validation of the revised Functional assessment of human immunodeficiency virus infection (FAHI) quality of life instrument. Quality of Life Research, 6, 572–584.CrossRefPubMed Peterman, A. H., Cella, D., Mo, F., & McCain, N. (1997). Psychometric validation of the revised Functional assessment of human immunodeficiency virus infection (FAHI) quality of life instrument. Quality of Life Research, 6, 572–584.CrossRefPubMed
14.
go back to reference Fritz, A., Percy, C., Jack, A., Kanagaratnam, S., Sobin, L., Parkin, D. M., et al. (2000). International classification of diseases for oncology (3rd ed., pp. 98–100). Geneva: World Health Organization. Fritz, A., Percy, C., Jack, A., Kanagaratnam, S., Sobin, L., Parkin, D. M., et al. (2000). International classification of diseases for oncology (3rd ed., pp. 98–100). Geneva: World Health Organization.
15.
go back to reference Brucker, P. S., Yost, K., Cashy, J., Webster, K., & Cella, D. (2005). General population and cancer patient norms for the Functional assessment of cancer therapy-general (FACT-G). Evaluation & the Health Professions, 28, 192–211.CrossRef Brucker, P. S., Yost, K., Cashy, J., Webster, K., & Cella, D. (2005). General population and cancer patient norms for the Functional assessment of cancer therapy-general (FACT-G). Evaluation & the Health Professions, 28, 192–211.CrossRef
16.
go back to reference Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41, 582–592.CrossRefPubMed Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41, 582–592.CrossRefPubMed
17.
go back to reference Biggar, R. J., Chaturvedi, A. K., Goedert, J. J., & Engels, E. A. (2007). HIV/AIDS Cancer Match Study (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. Journal of the National Cancer Institute, 99, 962–972.CrossRefPubMed Biggar, R. J., Chaturvedi, A. K., Goedert, J. J., & Engels, E. A. (2007). HIV/AIDS Cancer Match Study (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. Journal of the National Cancer Institute, 99, 962–972.CrossRefPubMed
18.
go back to reference Holly, E. A., & Lele, C. (1997). Non-Hodgkin’s lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: Allergies, prior medication use, and sexual practices. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, 211–222.PubMed Holly, E. A., & Lele, C. (1997). Non-Hodgkin’s lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: Allergies, prior medication use, and sexual practices. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, 211–222.PubMed
19.
go back to reference Centers for Disease Control and Prevention (2005). Reported CD4+ T-lymphocyte results for adults and adolescents with HIV/AIDS—33 states, 2005. HIV/AIDS Surveillance Supplemental Report, 11, 12. Centers for Disease Control and Prevention (2005). Reported CD4+ T-lymphocyte results for adults and adolescents with HIV/AIDS—33 states, 2005. HIV/AIDS Surveillance Supplemental Report, 11, 12.
Metadata
Title
Quality of life, characteristics and survival of patients with HIV and lymphoma
Authors
Catherine Diamond
Thomas H. Taylor
Hoda Anton-Culver
Publication date
01-03-2010
Publisher
Springer Netherlands
Published in
Quality of Life Research / Issue 2/2010
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9565-0

Other articles of this Issue 2/2010

Quality of Life Research 2/2010 Go to the issue